The American Journal of Hospice & Palliative Medicine, published by SAGE Publications Inc, is a leading peer-reviewed journal dedicated to advancing the field of hospice and palliative medicine. With its ISSN 1049-9091 and E-ISSN 1938-2715, the journal has been a vital resource since its inception in 1984, aiming to provide comprehensive insights into clinical practices, innovations, and research findings that enrich the quality of life for patients with serious illnesses. It holds a prestigious position as a Q2 journal in the field of medicine (miscellaneous), ranked #139 out of 636 in General Medicine with an impressive 78th percentile standing according to Scopus. The journal does not currently operate under an Open Access model, ensuring rigorous review and quality control of its content. Researchers, clinicians, and students are encouraged to engage with the latest developments and evidence-based practices in palliative care as the journal continues to shape discussions and policies in this critical area of healthcare.

Oncology Reports is a distinguished journal dedicated to advancing knowledge in the field of oncology. Published by Spandidos Publications Ltd, this journal has been a cornerstone in cancer research since its establishment in 1994 and is set to continue its impactful contributions until 2024. With ISSN 1021-335X and E-ISSN 1791-2431, it ranks in the Q2 category in Cancer Research, Medicine (Miscellaneous), and Oncology as of 2023, reflecting its solid standing in the academic community. The journal's current Scopus rankings position it notably within Medicine (Oncology) (#74/404, 81st percentile) and Biochemistry, Genetics and Molecular Biology (Cancer Research) (#67/230, 71st percentile), underscoring its rigorous peer-review process and the quality of its published research. Although not an open-access journal, Oncology Reports remains committed to disseminating vital information to researchers, professionals, and students, ensuring they stay at the forefront of developments in cancer studies. Its comprehensive scope promotes a multidisciplinary approach, encompassing clinical and experimental aspects of oncology, thus serving as an essential resource for those striving to understand and combat cancer.

ACTA ONCOLOGICA is a prestigious multidisciplinary journal published by Medical Journal Sweden AB, dedicated to advancing cancer research and clinical practice. As a key resource in the field of oncology, the journal aims to publish high-quality articles that cover significant developments in cancer biology, treatment modalities, and innovative imaging techniques. With an ISSN of 0284-186X and an E-ISSN of 1651-226X, ACTA ONCOLOGICA operates in the United Kingdom and is recognized for its substantial impact, currently holding a Q2 ranking in the categories of Hematology, Medicine (miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging in 2023. The journal’s commitment to disseminating pivotal research is reflected in its inclusion in Scopus, with rankings placing it in the top half of its fields. Though it does not currently offer Open Access, it remains an essential resource for researchers, healthcare professionals, and students seeking to stay informed on the latest trends and findings in oncology. Established in 1963, the journal continues to be a cornerstone of cancer research well into 2024.

Palliative Medicine Reports, published by MARY ANN LIEBERT, INC, is an esteemed Open Access journal dedicated to advancing the field of palliative care and pain management. Since its inception in 2020, this journal has established itself as an important platform for researchers and practitioners in the domains of Advanced and Specialized Nursing, Anesthesiology, and Pain Medicine. With an impressive Q2 ranking in both Advanced and Specialized Nursing and Anesthesiology and Pain Medicine, and a Q3 ranking in the Health (Social Science) category, it stands out as a reputable resource for disseminating high-quality research. The journal fosters an interdisciplinary approach, aiming to bridge gaps in knowledge and practice related to palliative care and the holistic needs of patients experiencing serious illness. Researchers, clinicians, and scholars are encouraged to contribute their work, benefitting from the journal's broad visibility and rigorously peer-reviewed process, ensuring that critical advancements in the field receive the attention they deserve.

Journal of Geriatric Oncology, published by Elsevier, stands at the intersection of geriatric medicine and oncology, addressing the unique needs and challenges of cancer management in older adults. Since its inception in 2010, this esteemed journal has played a pivotal role in advancing research and clinical practices, aiming to improve the quality of life and treatment outcomes for elderly cancer patients. With its impressive categorization in the 2023 Q2 quartile for both Geriatrics and Gerontology and Oncology, the journal demonstrates a noteworthy impact within its fields, ranking #153 out of 404 in Medicine – Oncology and #45 out of 116 in Medicine – Geriatrics and Gerontology. Researchers and healthcare professionals are encouraged to access critical insights through its rigorous peer-reviewed articles, which offer cutting-edge research findings and clinical applications. As the field continues to evolve, the Journal of Geriatric Oncology remains a vital resource for those dedicated to fostering innovation in geriatric oncology.

The Journal of Hospice & Palliative Nursing (ISSN: 1522-2179, E-ISSN: 1539-0705), published by Lippincott Williams & Wilkins, stands as a leading resource in the field of hospice and palliative care nursing. With an impressive impact factor and ranked in the Q1 quartile for Advanced and Specialized Nursing and Q2 quartile for Community and Home Care as of 2023, this journal serves as a critical platform for disseminating evidence-based practices and innovative research. It covers a broad spectrum of topics, aiming to improve patient experiences and enhance the quality of care for individuals with life-limiting conditions. Created to support healthcare professionals, researchers, and students in the United States and beyond, the journal invites contributions that stimulate scholarly dialogue and advance the practice of palliative nursing. With publication years converging from 1999 to 2024, it remains an invaluable asset to the nursing community, fostering advancements in this vital area of healthcare.

Onkologija is a distinguished open-access journal dedicated to the field of oncology, published by the Institute of Oncology Ljubljana. With its ISSN 1408-1741 and E-ISSN 1581-3215, this journal has become a crucial platform for researchers and healthcare professionals since its transition to open-access in 2008, allowing widespread dissemination of critical findings and innovations in cancer research and treatment. Located in Ljubljana, Slovenia, the journal aims to bridge the gap between clinical practice and research by publishing high-quality original articles, reviews, and case studies that address pivotal issues in oncology. Although specific metrics such as HIndex and Scopus ranks are currently unavailable, Onkologija’s commitment to advancing oncology knowledge is evident in its engaging publications that attract a diverse readership, making it an essential resource for anyone invested in the battle against cancer.

International Journal of Palliative Nursing is a renowned peer-reviewed journal dedicated to advancing the field of palliative care and nursing. Published by MA HEALTHCARE LTD in the United Kingdom, this journal has been a pivotal resource for healthcare professionals, researchers, and students alike since its inception in 2000. With an ISSN of 1357-6321, it is well-regarded for its commitment to high-quality research and practical insights, maintaining a Q3 category ranking in Advanced and Specialized Nursing. Despite its non-open access format, the journal offers a wealth of knowledge through a diverse array of articles that cover the latest advancements and best practices in palliative nursing. Its Scopus Rank at #36/63 reflects its respectable standing in the nursing community and highlights its contributions to the interdisciplinary realm of palliative care. The journal is an invaluable platform for fostering dialogue and sharing innovative approaches to nurture compassionate patient care.

Current Oncology Reports is a prestigious academic journal dedicated to the field of oncology, published by Springer and based in the United States. With an impressive impact factor and ranking as a Q1 journal in the 2023 category of Oncology, it positions itself among the top-tier publications within the discipline. Established in 1999, the journal has been a vital resource for researchers, professionals, and students alike, providing comprehensive insights and the latest advancements in cancer research and treatment. Through its rigorous peer-review process, Current Oncology Reports disseminates high-quality original articles, reviews, and clinical studies that foster collaboration and innovation in the oncology community. Although it currently operates under a subscription model, the journal remains committed to accessibility, ensuring that critical findings reach a broad audience. As such, it serves as an essential platform for those dedicated to the fight against cancer, making significant contributions to the evolving landscape of oncology.

JNCI Cancer Spectrum, published by Oxford University Press, is a leading open-access journal dedicated to advancing the field of cancer research and oncology. With an impressive impact demonstrated through its Q1 ranking in both Cancer Research and Oncology categories for 2023, this journal provides a vital platform for disseminating high-quality research and innovative findings in a rapidly evolving landscape. Since its inception in 2017, JNCI Cancer Spectrum has embraced open access, enhancing the accessibility of evidence-based knowledge to researchers, professionals, and students across the globe. Additionally, it boasts notable positions in Scopus rankings, with a strong performance in both the Medicine and Biochemistry, Genetics and Molecular Biology categories. The journal is committed to its objectives of fostering collaborative efforts and encouraging dialogue among experts, making it an essential resource for anyone involved in cancer research.